Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole vs HRT in Frozen Cycles for PCOS
NCT05168865Phase 4Withdrawn
- Sponsor
- Dubai Fertility Center
- Start
- Aug 2023
- Primary completion
- Feb 2024
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, open-label trial of letrozole in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Dubai Fertility Center. Primary endpoint: Live birth rate per embryo transfer at 9 months. Planned start Aug 2023; status: withdrawn.
02
Drugs
letrozole
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05168865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05168865.